|
Name |
Mollicellin C
|
Molecular Formula | C22H20O8 | |
IUPAC Name* |
4,9-dihydroxy-3-methoxy-1,7-dimethyl-2-(3-methylbut-2-enoyl)-6-oxobenzo[b][1,4]benzodioxepine-10-carbaldehyde
|
|
SMILES |
CC1=CC(=C(C2=C1C(=O)OC3=C(O2)C(=C(C(=C3O)OC)C(=O)C=C(C)C)C)C=O)O
|
|
InChI |
InChI=1S/C22H20O8/c1-9(2)6-14(25)16-11(4)18-21(17(26)20(16)28-5)30-22(27)15-10(3)7-13(24)12(8-23)19(15)29-18/h6-8,24,26H,1-5H3
|
|
InChIKey |
RPSLZGPKLQLZGH-UHFFFAOYSA-N
|
|
Synonyms |
Mollicellin C; 68436-82-8; MOLLICELLINE C; 11H-Dibenzo(b,e)(1,4)dioxepin-4-carboxaldehyde, 3,9-dihydroxy-8-methoxy-1,6-dimethyl-7-(3-methyl-1-oxo-2-butenyl)-11-oxo-; CHEBI:68802; 26Q0EO75R3; UNII-26Q0EO75R3; CHEMBL1081161; DTXSID60218563; 4,9-dihydroxy-3-methoxy-1,7-dimethyl-2-(3-methylbut-2-enoyl)-6-oxobenzo[b][1,4]benzodioxepine-10-carbaldehyde; C20046; Q27137187; 11H-DIBENZO(B,E)(1,4)DIOXEPIN-4-CARBOXALDEHYDE, 3,9-DIHYDROXY-8-METHOXY-1,6-DIMETHYL-7-(3-METHYL-1-OXO-2-BUTEN-1-YL)-11-OXO-; 3,9-dihydroxy-8-methoxy-1,6-dimethyl-7-(3-methylbut-2-enoyl)-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-4-carbaldehyde; 4,9-dihydroxy-3-methoxy-1,7-dimethyl-2-(3-methylbut-2-enoyl)-6-oxo-benzo[b][1,4]benzodioxepine-10-carbaldehyde; 7,14-dihydroxy-6-methoxy-4,12-dimethyl-5-(3-methylbut-2-enoyl)-10-oxo-2,9-dioxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene-15-carbaldehyde
|
|
CAS | 68436-82-8 | |
PubChem CID | 50200 | |
ChEMBL ID | CHEMBL1081161 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 412.4 | ALogp: | 4.1 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 119.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.245 |
Caco-2 Permeability: | -4.969 | MDCK Permeability: | 0.00001770 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.608 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.004 | Plasma Protein Binding (PPB): | 97.03% |
Volume Distribution (VD): | 0.519 | Fu: | 2.39% |
CYP1A2-inhibitor: | 0.741 | CYP1A2-substrate: | 0.842 |
CYP2C19-inhibitor: | 0.701 | CYP2C19-substrate: | 0.3 |
CYP2C9-inhibitor: | 0.83 | CYP2C9-substrate: | 0.817 |
CYP2D6-inhibitor: | 0.02 | CYP2D6-substrate: | 0.238 |
CYP3A4-inhibitor: | 0.428 | CYP3A4-substrate: | 0.193 |
Clearance (CL): | 1.468 | Half-life (T1/2): | 0.456 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.011 |
Drug-inuced Liver Injury (DILI): | 0.315 | AMES Toxicity: | 0.154 |
Rat Oral Acute Toxicity: | 0.998 | Maximum Recommended Daily Dose: | 0.962 |
Skin Sensitization: | 0.807 | Carcinogencity: | 0.429 |
Eye Corrosion: | 0.022 | Eye Irritation: | 0.954 |
Respiratory Toxicity: | 0.783 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005962 | 0.798 | D0WY9N | 0.282 | ||||
ENC000632 | 0.780 | D05QDC | 0.263 | ||||
ENC005960 | 0.758 | D0Q0PR | 0.252 | ||||
ENC005961 | 0.588 | D06GCK | 0.242 | ||||
ENC002677 | 0.578 | D0B1IP | 0.240 | ||||
ENC002864 | 0.573 | D0FX2Q | 0.238 | ||||
ENC002620 | 0.564 | D04FBR | 0.237 | ||||
ENC000921 | 0.561 | D03RTK | 0.235 | ||||
ENC000884 | 0.561 | D0O6KE | 0.218 | ||||
ENC005959 | 0.550 | D0V6OA | 0.214 |